These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16265879)

  • 1. Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development.
    Choy G; Liu JW; Chandra D; Tang DG
    Prog Drug Res; 2005; 63():115-45. PubMed ID: 16265879
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis and cancer chemotherapy.
    Makin G; Dive C
    Trends Cell Biol; 2001 Nov; 11(11):S22-6. PubMed ID: 11684438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway.
    Herrmann JL; Beham AW; Sarkiss M; Chiao PJ; Rands MT; Bruckheimer EM; Brisbay S; McDonnell TJ
    Exp Cell Res; 1997 Nov; 237(1):101-9. PubMed ID: 9417872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Bcl-2 for cancer therapy.
    Zhang L; Lu Z; Zhao X
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188569. PubMed ID: 34015412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of anti-cancer drugs mediated by apoptosis and autophagy].
    Shimizu S
    Nihon Rinsho; 2015 Aug; 73(8):1302-7. PubMed ID: 26281682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
    Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
    Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can targeting apoptosis resolve the cancer saga?
    Dlamini Z; Mbita Z; Ledwaba T
    Future Oncol; 2005 Jun; 1(3):339-49. PubMed ID: 16556008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
    Bonavida B; Vega MI
    Drug Resist Updat; 2005; 8(1-2):27-41. PubMed ID: 15939340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity to apoptosis between the human small and large intestinal mucosae: linkage with segment-specific regulation of BCL-2 homologs and involvement of signaling pathways.
    Gauthier R; Laprise P; Cardin E; Harnois C; Plourde A; Reed JC; Vézina A; Vachon PH
    J Cell Biochem; 2001; 82(2):339-55. PubMed ID: 11527158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
    Navolanic PM; Steelman LS; McCubrey JA
    Int J Oncol; 2003 Feb; 22(2):237-52. PubMed ID: 12527919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of apoptosis in the pathogenesis of rheumatoid arthritis].
    Kawakami A; Tanaka F; Tamai M; Nakamura H; Eguchi K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():100-5. PubMed ID: 15799326
    [No Abstract]   [Full Text] [Related]  

  • 13. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs.
    Pham CG; Bubici C; Zazzeroni F; Knabb JR; Papa S; Kuntzen C; Franzoso G
    Mol Cell Biol; 2007 Jun; 27(11):3920-35. PubMed ID: 17403902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival.
    Cook AB; Ziazadeh DR; Lu J; Jackson TL
    Math Biosci Eng; 2015 Dec; 12(6):1219-35. PubMed ID: 26775858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoside induces apoptosis and inhibits growth in pancreatic cancer via Bcl-2 family and NF-κB signaling pathway both in vitro and in vivo.
    Li Y; Wang Y; Li L; Kong R; Pan S; Ji L; Liu H; Chen H; Sun B
    Tumour Biol; 2016 Jun; 37(6):7345-55. PubMed ID: 26676634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications.
    Kabore AF; Johnston JB; Gibson SB
    Curr Cancer Drug Targets; 2004 Mar; 4(2):147-63. PubMed ID: 15032666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications.
    Chauhan D; Anderson KC
    Apoptosis; 2003 Aug; 8(4):337-43. PubMed ID: 12815276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting BCL-2 regulated apoptosis in cancer.
    Campbell KJ; Tait SWG
    Open Biol; 2018 May; 8(5):. PubMed ID: 29769323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.
    Qin JZ; Bacon PE; Chaturvedi V; Bonish B; Nickoloff BJ
    Exp Dermatol; 2002 Dec; 11(6):573-83. PubMed ID: 12473065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.